chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient came in for and received a booster dose of Moderna. Eight months later, informed by the immunization registry the patient received too many vaccinations per the guidelines. This was their 5th dose. No adverse reactions to the vaccine reported.
Severe swelling of arm, redness, pain, fever, injection site hot, Nausea.
I have been experiencing Head Trimmers on a daily basis since receiving the vaccine. I went to see my PCP and was referred to a Neurologist who examined me and diagnosed with Primary Head Trimmers that are not associated with Parkinson's disease on 06/18/2021.  Since then the Head Trimmers are more prevalent along with causing my hands to shake..
positive COVID-19 test with no symptoms; positive COVID-19 test with no symptoms; This is a spontaneous report from a contactable Nurse reporting for herself.  A 36-year-old female patient received the first dose of bnt162b2 (BNT162B2) vaccine,  via an unspecified route of administration in the left arm, on 22Dec2020 16:30 at single dose for Covid-19 immunisation.  The patient medical history and concomitant medications were not reported. On 28Dec2020 the patient resulted positive to Covid-19 test (nasal swab), but the patient did not show symptoms.   Information on the lot/batch number has been requested.
Instead of pt receiving Pneumococcal he received BEXSERO by accident. Dr. was informed. I called the pt and he was informed of the situation. Pt shouldn't have any adverse reactions. Nurse Manager was informed as well.
APPROXIMATELY 7 1/2 months later on 8/7/2016 Admitted TO MEDICAL CTR FOR SHORTNESS OF BREATH AND PNEUMONIA TO THE EMERGENCY ROOM THEN ADMITTED OVERNIGHT. On 12/15/2015 - patient received the Zostavax vaccine in the doctor office. Interestingly, the insurance companies, or the supplemental insurance would not cover the vaccine, the vaccine from Merck pharma has been removed from public use. Subsequently, patient had developed pneumonia 7 1/2 mo. later, in the summer, as well as shortness of breath. These were unusual occurrences in a short span of time, occurring in the summer & no prior history of pneumonia; After a follow up visit with the pulmonologist in November 2017, he advised an inflamation of the pancreas which led to a further diagnosis of cancer. I believe this accelerated patient's condition, whereby, there was no family history on her side of any cancer.
blood sugar went down to 100 from 230; felt warm for 15 minutes; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE DECREASED (blood sugar went down to 100 from 230) and FEELING HOT (felt warm for 15 minutes) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced BLOOD GLUCOSE DECREASED (blood sugar went down to 100 from 230) and FEELING HOT (felt warm for 15 minutes). On 16-Mar-2021, BLOOD GLUCOSE DECREASED (blood sugar went down to 100 from 230) had resolved. At the time of the report, FEELING HOT (felt warm for 15 minutes) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Mar-2021, Blood glucose decreased: blood sugar went down to 100 from 230.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Treatment information in response to events was not provided. Action taken with mRNA-1273 in response to the event was unknown
Less than 24 hours after receiving the first shot in the Moderna C19 series, I developed excruciating nerve pain in my left shoulder, arm, back, and neck. I also had patches of skin that felt like they were on fire. I still have numb patches of skin on my forearm and wrist. Lidocaine patches helped for the skin pain. Gabapentin did nothing at all to relieve deeper nerve pain. After the pain subsided I realized that several muscles were paralyzed and that I could not lift my arm above my head. Nearly 30 days later, the pain has subsided but I still do not have control of several muscles in my shoulder. My next step is to go see a neurologist.
Chills, fever, fatigue and stomach cramping.  Side effects not as severe as first shot
This spontaneous report as received from a healthcare worker (C.M.A.) refers to a 50 year old female patient with psoriasis and no drug reactions/allergies. On 21-FEB-2014 the patient was vaccinated with ZOSTAVAX lot # J006158, expiry date 30-AUG-2014, 0.65 ml, subcutaneous. There was no concomitant medication. The patient felt dizzy "right away" after receiving the ZOSTAVAX and then a "short time after" developed hot flashes and diarrhea. She reported that "later that night" on 21-FEB-2014, the patient developed redness, swelling, and "warm to touch" at the injection site. She reported that the redness at the injection site has gotten "a little bit better" since an unspecified date. The patient was seen by physician on 25-FEB-2014, no treatment was given and no lab test was performed. The outcome of adverse event (dizzy, hot flashes, diarrhea, swelling and warm to touch at injection site) was not reported. Additional information has been requested.
Numbness and tingling of lower face, as occurs when a herpes lesion is going to break out.  V3 distribution, no motor loss.  Started 2 days after second covid innoculation.  Occassionally gets better, but recurs again after a short period of time.  I had polio and had some facial nerves involvement; am also a physician, retired now.
Severe Fatigue in Legs and lower extremities.  Since 3/28/2021
No side effects reported; Improperly stored vaccine was administered.; This spontaneous report has been received from a nurse concerning a patient of unknown age and gender.  The patient's concurrent conditions, medical history, concomitant therapies and drug/allergy history were not reported.  On 21-JUN-2023, the patient was vaccinated with an improper stored dose of varicella virus vaccine live (oka/merck) (VARIVAX), lot # U025789 (expiration date reported and upon internal validation established as 19-AUG-2023) for prophylaxis (dose, anatomical location, and route of administration were not reported). The vaccine was stored at a temperature of 6 Celsius (C) degrees for 7 hours. It did not have previous temperature excursions.  No side effects were reported.
PATIENT CAME IN REPORTING SHE JUST CAME FROM AN URGENT CARE AND THEY SAID SHE HAD CELLULITIS AS A RESULT OF THE FLU SHOT SHE RECEIVED.  THEY SAID TO WATCH THE AREA AND IF IT SPREADS SHE IS TO GO BACK TO THE URGENT CARE FOR FOLLOW UP.  THE FLU SHOT WAS GIVEN THREE DAYS BEFORE SHE WENT TO THE URGENT CARE FOR TREATMENT.
Coughs more/no mucus in the cough; This is a spontaneous report from a contactable consumer (patient). This female patient of unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number unknown) via an unspecified route of administration on 06Mar2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient called to inquire if she had to go to the same pharmacy to get both doses of BNT162B2. She reported she got her first dose of BNT162B2 on 06Mar2021 and last week she noticed that she coughed more. She stated there was no mucus in the cough and she planned to take guaifenesin (MUCINEX) for her cough. The clinical outcome of coughs more/no mucus in the cough was unknown.   Information about batch/lot number has been requested.  Follow-up attempts are completed. No further information is expected.
Pain at injection site progressing to pain radiating down entire arm. Arm remained sore and red rash developed around injection site and extending to upper arm.
Severe edema; injection site reaction; This spontaneous report was received from a physician via company representative and referred to a male patient of an unknown age. The patient's concurrent conditions, medical history and concomitant medications were not reported. On an unknown date ,the patient was vaccinated with his first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9)(dosing details, route, frequency and lot# were unknown) and had an injection site reaction that consisted of severe oedema that covered the whole deltoid area of an unspecified arm. It was reported that the oedema was 4 cm in diameter.The outcome of oedema and injection site reaction was unknown. Causality assessment was not provided. No PQC found.
Fuzzy sensation in the arm; Pain at the site of the injection; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Fuzzy sensation in the arm) and VACCINATION SITE PAIN (Pain at the site of the injection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 091D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Aug-2021, the patient experienced VACCINATION SITE PAIN (Pain at the site of the injection). On 07-Aug-2021, the patient experienced HYPOAESTHESIA (Fuzzy sensation in the arm). On 02-Aug-2021, VACCINATION SITE PAIN (Pain at the site of the injection) had resolved. At the time of the report, HYPOAESTHESIA (Fuzzy sensation in the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications or treatment details were reported.
Red, itchy, raised area at injection site 1 weeks after vaccination. Lasting approx 5 days
This spontaneous report has been received from a 73 year old female consumer reporting on herself. The patient's pertinent medical history included iodine allergy. On 15-OCT-2007 the patient was vaccinated with ZOSTAVAX 19400 PFU (dose, and lot #, were not provided). Concomitant therapies included anastrozole, unspecified antibiotic and ibuprofen. In August 2015 the patient underwent a breast cancer surgery on her left side (reported as pertinent medical history). Subsequently, it was reported that the experienced an apparent outbreak of shingles; since on 10-JAN-2016 she experienced, back pain and hives on her left side, for that reason on 17-JAN-2016 the patient sought medical attention, at an unspecified medical clinic for the "hives on her left side" that was still present, she was treated with an antiviral and scrape test to test for shingles was done at the site of the lesion. The consumer reported that the results of the scrape test had not come in yet. At the time of the report the outcome of breast cancer was unknown and the outcome of herpes zoster, was reported as recovering. The relatedness between the events and ZOSTAVAX was not reported. Upon internal review the breast cancer was considered medically significant event. Additional information has been requested.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE RESPIRATORY FAILURE, UNSPECIFIED ACUITY
Patient reports that her symptoms started within 5 minutes of getting the vaccine.  Started with facial numbing then followed by a bad headache and joint pain all happening within 15 minutes.  Facial numbness was her first symptom that started.  In the next hour she had chills, scratchy throat, itchy and dry eyes.  Slept the rest of the day.  The following day she had headaches, chills terrible body aches.  4/12/21 she developed facial swelling under her chin, lymph nodes inflamed/enlarged, chills, body aches, slight headache, cough.  Took IB to help with symptoms.  She still continues to have side effects today, (4/16/21) which include body aches, fatigue and still "not feeling right."
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose:1/07/2021.pfizer Lot#EL3248 2nd dose:01/28/21.pfizerLot#EN5318 Diagnosed Covid positive: 03/19/21 Exposure:Unknown Symptoms:Cough,Headache, body aches.
On 20Nov2005 the patient had severe chest pain and evaluation showed 3mm ST elevation on ECG; pain relieved with one Aspirin and one sublingual nitro.  Total 90 mins pain before sought care and got nitro.  Sent to hospital where was pain free but got lytic therapy for continued ST elevation.  Cardiac enzymes positive with total CK 1394, total MB 96.  Cardiac risk factors of smoking and low HDL (HDL 24 on 23NOV05).  Smoker of 1 ppd for over 20 years.  Pain free now since 20November after first nitroglycerine administration.  Cardiac cath on 23NOV (sent to hospital on 22NOV05) showed normal coronary arteries with no thrombus, no muscle bridging, and no spasm.  Wall motion by LV-gram and by echocardiogram on 23NOV was normal, with EF 60%.  Normal echocardiogram other than mild left atrial enlargement.  My assessment as his cardiologist:  Acute ST elevation MI due to vasospasm and possibly some degree of acute plaque rupture or thrombus, but relieved with nitroglycerine.  90 minutes of pain with enzyme proven cardiac injury.  Likely related to a combination of factors: (1) Patient was febrile, had severe local reaction to vaccinia site with erythema and pain and local lymphadenopathy and was feeling generally ill from 18-20NOV 2005, (2) Patient had upper respiratory illness starting 5NOV2005 that he felt became worse and more symptomatic over same time period of 18-20NOV05, (3) Smoker chronically and at the time of event, and (4) Possible abnormal lipids lending to endothelial dysfunction.  It seems likely that the brisk local and systemic reaction to the vaccine played a role in the event.
I had exposure to Covid on 12/5 but had no symptoms but on 12/8 I tested positive to Covid.  Between 12/10-12/13 I took multiple tests which were all negative but on 12/28 I developed a sore throat which turned into a cough and sinus congestion and on 1/1 I took an at home COVID test and it was positive as well,  followed by 2 more additional test one of which was a PCR and all were positive as well.  My symptoms are resolving current
1st shot- No Adverse reactions. 2nd shot- some fatigue at about 10hrs post injection. That night experienced some chills and shaking for about 3 hrs. Fatigue lasted about about 2 days. 3rd booster shot - left arm soreness at injection site. At about 12 hrs after injection chills and some minor shaking. Next day very tired, with flu like symptoms. That night about 2AM started experiencing chills and some shaking. That advanced to severe chills and shaking to the point of convulsions. This lasted for about 4 hrs. Next day very fatigued with some minor flu like symptoms. Day three started feeling better. Day four seemed to be normal.
sore throat; ears feel like she just got off a plane; This is a spontaneous report received from a contactable Consumer from medical information team. The reporter is the patient.  A 27 year-old female patient received bnt162b2 (BNT162B2), administration date 05Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: OROPHARYNGEAL PAIN (non-serious) with onset Mar2021, outcome "unknown", described as "sore throat"; EAR DISCOMFORT (non-serious) with onset Mar2021, outcome "unknown", described as "ears feel like she just got off a plane".  Additional information: She is calling about the Covid 19 vaccine. She got her first dose on 05Mar2021 and the past 2 days she feels like she has a sore throat and her ears feel like she's just gotten off an airplane. Her second dose is scheduled for today, she is asking if she should get the second vaccine. She declines to file a safety report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
severe asthma; This is a spontaneous report from a Pfizer sponsored program from a contactable consumer (patient's husband). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 29Mar2021 as single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported.  The reporter wanted to check if the patient could take prednisone since she was having severe asthma on 12Apr2021. She got the 1st vaccine 29Mar2021 and the 2nd dose was on 18Apr2021. She wanted to reschedule the 2nd dose so that the vaccine won't interfere with the prednisone. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Malaise, including high fever (102.1 F) before starting treatment with acetaminophen. Fever lasted 3 days. Red rash in the shape of the country of Italy at the injection site (~3x4 inches). New sensitivity to mosquito bites where previously there was not.
PATIENT PAT HAD SEVERE PAIN AND LOSS of  MOTION in left ARM from Day after SHOT ContiNuing untiNl preseNt
This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back Pain), HEADACHE (Headache), ARTHRALGIA (Joint pain), MYALGIA (Muscle pain) and NAUSEA (Nausea) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. ew0150 and ew0169) for COVID-19 vaccination. The patient's past medical history included Hepatitis C and Liver disorder (Subsequent liver issues after Hepatitis C). Concurrent medical conditions included Hypertension.On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-May-2021, the patient experienced BACK PAIN (Back Pain), HEADACHE (Headache), ARTHRALGIA (Joint pain), MYALGIA (Muscle pain) and NAUSEA (Nausea). At the time of the report, BACK PAIN (Back Pain), HEADACHE (Headache), ARTHRALGIA (Joint pain), MYALGIA (Muscle pain) and NAUSEA (Nausea) had not resolved.    The concomitant medications include blood pressure medication. No treatment information was provided.
This spontaneous report was received from a medical assistant and refers to a 19 month-old (reported also as 2 year-old), female patient who did not have any known drug reactions or allergies (birth weigh 5lb 2oz reported also as 5lb 20 oz.) There was no information about the patient's concomitant therapy or medical history provided. The patient did not have any illnesses at the time of vaccination. On 20-OCT-2015 at 09:15 (am), the patient was vaccinated with improperly stored dose of VARIVAX lot # L013068, subcutaneously in the right arm for prophylaxis (dose and expiration date were not reported).        The vaccination was in privates doctor's office and administered VARIVAX was purchase with public funds. No adverse event was reported. Previous temperature excursions, the range and time of temperature excursion the administered VARIVAX experienced were not reported. It was unspecified if a digital data logger was involved. A signed informed consent form was not obtained. This is one of several reports from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1611USA014213: US-009507513-1702USA004104: US-009507513-1702USA004102: US-009507513-1702USA004103: US-009507513-1702USA004110: US-009507513-1611USA008278: US-009507513-1702USA004107: US-009507513-1702USA004106: US-009507513-1702USA004105:
Little red bumps on random spots of my arms. Was not hives. Lasted from 11pm on 1/5/20 to about 6pm on 1/6/20. Took Benadryl to keep it down. Now, just have a bruise on arm.
I had a mild headache on the day of the vaccine and for the following two days after.  On day 3, I developed a severe migraine headache that lasted for 5 days. At times, the pain was so intense that it woke me from my sleep and it was difficult to hold my head up. I saw my doctor for the headache on day 3 of the migraine who determined I did not need emergency care but should consult a neurologist and seek an MRI with contrast.  I will be making these appointments in the near future.  I attempted to treat the migraine with ibuprofen  as directed by my doctor but it did not relieve the symptoms.  I have never experienced a headache that lasted this long or of this type of intensity in my life. Total time the headache lasted was 8 days. And I am still experiencing mild head pain now.
soreness at injection site since 11/15/2009.  morning of 12/15/2009 arm very painfull, swollen,hot and red. temperature of 100 degrees.  visit to primary MD, antibiotics prescribed, follow up visit in 6 days.
Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 15-Jul-2022; No adverse event; Patient administered the vaccine after the 30 day by used; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 15-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 59-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 15-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 day by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 15-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 15-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 day by used) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 15-Jul-2022).    No concomitant product use was reported. It was reported that, patient received half dose. Vial did not undergo any temperature excursions. The vial was initially stored in the refrigerator on 4 Jun 2022. No treatment information was provided.
symptomatic w upper respiratory symptoms; break through COVID diagnosis per urgent care/positive COVID test; break through COVID diagnosis per urgent care/positive COVID test; This is a spontaneous report from a contactable consumer (patient). A 72-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 17Feb2021 as Dose number unknown, Single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 31Jul2021, patient experienced break through COVID diagnosis per urgent care/positive covid test, symptomatic w upper respiratory symptoms on an unspecified date. Reported that event took place after use of product. Patient did not wish to be contacted for follow-up. The patient underwent lab tests and procedures which included COVID test: positive on 31Jul2021. The clinical outcome of events was unknown.  No follow-up attempts are possible. No further information is expected.